A model which predicts maintenance warfarin dosage requirements from the response to a single dose. 1985

G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
January 1982, Therapeutic drug monitoring,
G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
January 1983, Drug intelligence & clinical pharmacy,
G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
January 1985, Clinical pharmacy,
G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
October 1979, American journal of hospital pharmacy,
G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
January 1981, The Journal of the American Osteopathic Association,
G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
March 1985, Journal of clinical and hospital pharmacy,
G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
April 2010, Clinical pharmacology and therapeutics,
G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
January 1984, Clinical pharmacy,
G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
August 2009, Journal of thrombosis and haemostasis : JTH,
G M Peterson, and S McLean, and D M Jupe, and R L Griffith, and J R Roberts
March 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
Copied contents to your clipboard!